Benedict Maniscalco
Cardiovascular Disease · Tampa, FLNPI 1679560486
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 114 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $887 and has fallen 97.5% since, to $22 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in FL, where the typical reported total is $2,774.
Across 114 payments — averaging $20.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$393
- Abbott$331
- Boehringer Ingelheim$212
- Amgen$180
- Johnson & Johnson$154
- Merck$131
- plus $922 from 16 others
What the payments were for
- Food & beverage$2,311100%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 22 | $393 |
| Abbott | 13 | $331 |
| Boehringer Ingelheim | 9 | $212 |
| Amgen | 10 | $180 |
| Johnson & Johnson | 11 | $154 |
| Merck | 7 | $131 |
| Biotronik Inc. | 1 | $128 |
| Kowa Pharmaceuticals America, Inc. | 8 | $127 |
| Boston Scientific | 7 | $115 |
| Actelion Pharmaceuticals US, Inc. | 4 | $96 |
| Astellas Pharma US Inc | 3 | $70 |
| AstraZeneca | 3 | $55 |
| Bard Peripheral Vascular, Inc. | 1 | $52 |
| Arbor Pharmaceuticals, Inc. | 3 | $52 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $51 |
| Novo Nordisk | 2 | $43 |
| Preventice Services, LLC | 2 | $40 |
| Cvrx, Inc. | 1 | $25 |
| Amarin Pharma, Inc. | 1 | $23 |
| Medtronic | 1 | $18 |
| Aegerion Pharmaceuticals, Inc. | 1 | $16 |
| Bardy Diagnostics, Inc. | 1 | $10 |
How this compares
$2,322 in reported general payments places this provider in the 45th percentile of 1,740 cardiovascular disease providers in Florida.
Other cardiovascular disease in Tampa
- Hiram BezerraTampa$698K
- James SmithTampa$324K
- David WilsonTampa$258K
- Robby WuTampa$190K
- Jason FelibertiTampa$138K
- Samip VasaiwalaTampa$126K
- Kevin MakatiLutz$1.6M
- William OneillNaples$637K
- Theodore FeldmanMiami$637K
- John Gerald CantoLakeland$588K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.